Immix Biopharma, Inc. (IMMX) Q1 2026 Earnings
IMMX·Reported May 7, 2026
Diluted EPS came in at $-0.18 (-20.0% YoY), beat the $-0.18 consensus by $0.00.
Diluted EPS
$-0.18beat by $0.00
Consensus: $-0.18
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Immix Biopharma, Inc.'s Q1 2026 earnings report.
Immix Biopharma, Inc. (IMMX) reported Q1 2026 earnings on May 7, 2026.
Immix Biopharma, Inc. reported diluted EPS of $-0.18 for Q1 2026.
EPS beat the consensus estimate of $-0.18 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 20.0% from $-0.15.
You can read the 10-Q periodic report (0001493152-26-021764) directly on SEC EDGAR. The filing index links above go to sec.gov.